ArticleBMJ open2025

Neoadjuvant stereotactic body radiotherapy combined with chemotherapy and Ivonescimab for Chinese luminal-type breast cancer patients: study protocol for a single-arm, open-label, phase II trial.

Caixun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.